Patent 10900034 was granted and assigned to Agilent Technologies on January, 2021 by the United States Patent and Trademark Office.
The present invention relates to modified guide RNAs and their use in clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems.